title: Full results on risks of epoetin emerge 14 years after major dialysis study.
authors.forename: Keith
authors.initials: K
authors.lastname: Epstein
mesh_terms: D000740:Anemia / Q000150:complications / Q000188:drug therapy*; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects*; D006397:Hematinics / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007674:Kidney Diseases / Q000150:complications* / Q000628:therapy*; D011358:Product Surveillance, Postmarketing; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D006435:Renal Dialysis
chemical_list: D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa